Performance of methods for detection of extended-spectrum beta-lactamases applied to clinical enterobacterial strains producing IBC-type beta-lactamases.
Lebessi
E
E
Stamos
G
G
Foustoukou
M
M
Vourli
S
S
Legakis
N J
NJ
Tzouvelekis
L S
LS
D002442:Ceftazidime / Q000494:pharmacology; D019818:Clavulanic Acid / Q000494:pharmacology; D004338:Drug Combinations; D024881:Drug Resistance, Bacterial; D004755:Enterobacteriaceae / Q000187:drug effects* / Q000201:enzymology; D006801:Humans; D008826:Microbial Sensitivity Tests; D001618:beta-Lactamases / Q000032:analysis* / Q000378:metabolism; D047090:beta-Lactams / Q000494:pharmacology*
D004338:Drug Combinations; D047090:beta-Lactams; D019818:Clavulanic Acid; D002442:Ceftazidime; C413407:integron-associated beta-lactamase 1; D001618:beta-Lactamases